|
Back to Home » March 2018 News » Harvard bioengineers' biomaterial-based cancer immunotherapies to be developed by Novartis |
Harvard bioengineers' biomaterial-based cancer immunotherapies to be developed by Novartis |
March 20, 2018
BOSTON, March 20, 2018 /PRNewswire-USNewswire/ -- The Wyss Institute for Biologically Inspired Engineering at Harvard University and the Harvard John A. Paulson School of Engineering and Applied Sciences (SEAS) announced today that Novartis will have access to commercially develop their...
Source URL: https://www.prnewswire.com/news-releases/harvard-bioengineers-biomaterial-based-cancer-immunotherapies-to-be-developed-by-novartis-300615921.html
|
|
|
|
